Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

The study, conducted on rats with diabetic nephropathy, found that PEITC has the potential to reverse serious kidney damage.

A new cell therapy trial from the University of Galway has shown encouraging results for people with type 2 diabetes and ...

GPs struggle to integrate albuminuria screening for chronic kidney disease due to confusion over prescribing and interpreting ...

According to Coherent Market Insights, the global Diabetic Kidney Disease Market size was valued at USD 3.03 Billion in 2024 and is projected to reach USD 4.21 Billion by 2031, registering a CAGR of 4 ...

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression to chronic kidney disease ...